Expertise in
18
conditions

Dr. Michael Glantz

Neurology
Office
30 Hope Dr Ste 1200, 
Hershey, PA 
Expertise in
18
conditions
Office
30 Hope Dr Ste 1200, 
Hershey, PA 

Overview

Michael Glantz is a Neurologist practicing medicine in Hershey, Pennsylvania.

Dr. Glantz is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, Brain Tumor, and Thrombectomy.

He is actively involved in clinical research, co-authoring 72 peer reviewed articles and participating in 7 clinical trials.

Specialties

Neurology

Licenses

Neurological Surgery in PA

Hospital Affiliations

North Adams Regional Hospital Corporation
Berkshire Medical Center
Fairview Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 7 Less Insurance Carriers -

Locations

Office
30 Hope Dr Ste 1200, Hershey, PA 17033
Other Locations
Berkshire Internists of BMC
777 North St, Pittsfield, MA 01201

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
Enrollment Status: Active_not_recruiting
Publish Date: April 15, 2026
Intervention Type: Drug
Study Drugs: Berubicin, Lomustine
Study Phase: Phase 2
An Open-label Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Tirabrutinib in Patients With Primary Central Nervous System Lymphoma (PCNSL)
An Open-label Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Tirabrutinib in Patients With Primary Central Nervous System Lymphoma (PCNSL)
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2026
Intervention Type: Drug
Study Phase: Phase 2
A Phase I/II Study of the Combination of Indoximod and Temozolomide for Adult Patients With Temozolomide-Refractory Primary Malignant Brain Tumors
A Phase I/II Study of the Combination of Indoximod and Temozolomide for Adult Patients With Temozolomide-Refractory Primary Malignant Brain Tumors
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 1/Phase 2
A Biospecimen Collection Study to Evaluate the Pharmacokinetic, Pharmacodynamic, and Resistance Profile to Trametinib and Dabrafenib in BRAF-V600E Mutated Recurrent Gliomas
A Biospecimen Collection Study to Evaluate the Pharmacokinetic, Pharmacodynamic, and Resistance Profile to Trametinib and Dabrafenib in BRAF-V600E Mutated Recurrent Gliomas
Enrollment Status: Terminated
Publish Date: October 06, 2023
Intervention Type: Procedure
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

72 Total Publications

Predicting late radiation-associated neurocognitive and endocrine toxicity in patients with brain tumors.
Predicting late radiation-associated neurocognitive and endocrine toxicity in patients with brain tumors.
Journal: Journal of neuro-oncology
Published: April 10, 2026
Similar Doctors
Expertise in
29
conditions
Dr. Sankar Bandyopadhyay
Neurology
Expertise in
29
conditions
Dr. Sankar Bandyopadhyay
Neurology
Referral may be required

Penn State Health Medical Group-Hope Drive Radiology

30 Hope Dr, 
Hershey, PA 
 (231.3 miles away)
717-531-3828
Languages Spoken:
English
See accepted insurances

Sankar Bandyopadhyay is a Neurologist practicing medicine in Hershey, Pennsylvania. Dr. Bandyopadhyay is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Rigid Spine Syndrome, X-Linked Myotubular Myopathy, and Centronuclear Myopathy.

Expertise in
9
conditions
Dr. Sol De Jesus
Neurology
Expertise in
9
conditions
Dr. Sol De Jesus
Neurology
Referral may be required

Office

30 Hope Dr Ste 1300, 
Hershey, PA 
 (230.3 miles away)
717-531-0003
Languages Spoken:
English
See accepted insurances

Sol De Jesus is a Neurologist practicing medicine in Hershey, Pennsylvania. Dr. De Jesus is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Movement Disorders, Parkinson's Disease, Essential Tremor, Drug Induced Dyskinesia, and Deep Brain Stimulation.

Expertise in
29
conditions
Dr. Zachary Simmons
Neurology
Expertise in
29
conditions
Dr. Zachary Simmons
Neurology
Referral may be required

Office

30 Hope Dr Ste 1300, 
Hershey, PA 
 (230.3 miles away)
717-531-3828
Experience:
44+ years
Languages Spoken:
English
See accepted insurances

Zachary Simmons is a Neurologist practicing medicine in Hershey, Pennsylvania. He has been practicing medicine for over 44 years. Dr. Simmons is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy Type 3, and Spinal and Bulbar Muscular Atrophy.

Frequently Asked Questions about Dr. Michael Glantz

How do I make an appointment with Dr. Michael Glantz?

You can book an appointment with Dr. Michael Glantz by calling their office at 717-531-3828. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael Glantz a top-rated expert for Astrocytoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael Glantz is classified as an Elite expert for Astrocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael Glantz specialize in?

While Dr. Michael Glantz is a Neurology, they have specific expertise in Astrocytoma, Glioblastoma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Michael Glantz participate in research or clinical trials?

Yes. Dr. Michael Glantz has published 72 articles and abstracts on conditions like Astrocytoma. You can view a list of Dr. Michael Glantz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael Glantz accept my insurance?

Dr. Michael Glantz accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 717-531-3828 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Glantz's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile